Literature DB >> 8173841

Inducible cyclooxygenase (COX-2): a safer therapeutic target?

I Appleton, A Tomlinson, D A Willoughby.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8173841     DOI： 10.1093/rheumatology/33.5.410

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN： 0263-7103


× No keyword cloud information.
  6 in total

1.  Professor Derek Albert Willoughby (1930-2004).

Authors:  K D Rainsford
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

2.  Effect of LLLT Ga-Al-As (685 nm) on LPS-induced inflammation of the airway and lung in the rat.

Authors:  F Aimbire; R Albertine; R G de Magalhães; R A B Lopes-Martins; H C Castro-Faria-Neto; R A Zângaro; M C Chavantes; M T T Pacheco
Journal:  Lasers Med Sci       Date:  2005-06-18       Impact factor: 3.161

Review 3.  The clinical implications of inhibition of the inducible form of cyclo-oxygenase.

Authors:  C Richardson; P Emery
Journal:  Drug Saf       Date:  1996-10       Impact factor: 5.606

Review 4.  Misoprostol/NSAID fixed combinations. Help or hindrance in clinical practice?

Authors:  A Isdale; V Wright
Journal:  Drug Saf       Date:  1995-05       Impact factor: 5.606

Review 5.  Nonsteroidal anti-inflammatory drug-induced gastrointestinal toxicity: new insights into an old problem.

Authors:  N M Davies; J L Wallace
Journal:  J Gastroenterol       Date:  1997-02       Impact factor: 7.527

Review 6.  Selective inhibitors of cyclooxygenase-2. Potential in elderly patients.

Authors:  N M Davies; J L Wallace
Journal:  Drugs Aging       Date:  1996-12       Impact factor: 3.923
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.